Effect of Intravenous Fluid Therapy on Postoperative Vomiting in Children Undergoing Otorhinolaryngological Surgery
1 other identifier
interventional
100
1 country
1
Brief Summary
The purpose of this randomized clinical trial is to evaluate the interaction of intravenous fluid therapy during otorhinolaryngological surgery, on postoperative vomiting. The hypothesis is that perioperative supplemental intravenous fluid administration reduces the incidence of postoperative vomiting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Jul 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
April 10, 2012
CompletedFirst Posted
Study publicly available on registry
April 11, 2012
CompletedMay 10, 2012
May 1, 2012
1.7 years
April 10, 2012
May 8, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Vomiting at 24 hours postoperative
Presence of at least one episode of vomiting in the first 24 hours postoperative
First 24 hours postoperative
Study Arms (2)
10 mL/kg/h lactated Ringer's solution
ACTIVE COMPARATORGroup 1, 10 mL/kg/h lactated Ringer's solution
30 mL/kg/h lactated Ringer's solution
EXPERIMENTALGroup 2, 30 mL/kg/h lactated Ringer's solution
Interventions
After induction, IV access was established and children were randomly allocated to receive one of two interventions: Group 1, 10 mL/kg/h lactated Ringer's solution; Group 2, 30 mL/kg/h lactated Ringer's solution.
Eligibility Criteria
You may qualify if:
- ASA physical status I or II
- Age 1-12 yr
- Scheduled for elective tonsillectomy or adenotonsillectomy
You may not qualify if:
- History of diabetes
- History of mental retardation
- Obesity (BMI ≥95th percentile for age and sex)
- Intake of antiemetic or psychoactive medication within 24 hours before surgery
- Known gastroesophageal reflux
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Clinico Universidad Catolica
Santiago, Santiago Metropolitan, Chile
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Profesor Asociado, Departamento de Anestesiología
Study Record Dates
First Submitted
April 10, 2012
First Posted
April 11, 2012
Study Start
July 1, 2010
Primary Completion
March 1, 2012
Study Completion
March 1, 2012
Last Updated
May 10, 2012
Record last verified: 2012-05